nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—ABCB1—melanoma	0.234	1	CbGaD
Cyclophosphamide—CYP3A4—Temozolomide—melanoma	0.0712	0.189	CbGbCtD
Cyclophosphamide—CYP2D6—Vemurafenib—melanoma	0.0614	0.163	CbGbCtD
Cyclophosphamide—CYP3A7—Docetaxel—melanoma	0.0458	0.122	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0458	0.122	CbGbCtD
Cyclophosphamide—ABCB1—Dactinomycin—melanoma	0.0433	0.115	CbGbCtD
Cyclophosphamide—CYP3A4—Vemurafenib—melanoma	0.039	0.104	CbGbCtD
Cyclophosphamide—CYP3A5—Docetaxel—melanoma	0.0343	0.0912	CbGbCtD
Cyclophosphamide—ABCB1—Docetaxel—melanoma	0.0224	0.0593	CbGbCtD
Cyclophosphamide—CYP3A4—Docetaxel—melanoma	0.0134	0.0356	CbGbCtD
Cyclophosphamide—Pneumonia—Temozolomide—melanoma	0.000394	0.0011	CcSEcCtD
Cyclophosphamide—Phlebitis—Docetaxel—melanoma	0.000392	0.0011	CcSEcCtD
Cyclophosphamide—Hepatitis—Dactinomycin—melanoma	0.000389	0.00109	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000388	0.00109	CcSEcCtD
Cyclophosphamide—Flushing—Bleomycin—melanoma	0.000387	0.00108	CcSEcCtD
Cyclophosphamide—Body temperature increased—Vemurafenib—melanoma	0.000387	0.00108	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Temozolomide—melanoma	0.000384	0.00107	CcSEcCtD
Cyclophosphamide—Swelling—Docetaxel—melanoma	0.000383	0.00107	CcSEcCtD
Cyclophosphamide—Stomatitis—Temozolomide—melanoma	0.000382	0.00107	CcSEcCtD
Cyclophosphamide—Deafness—Docetaxel—melanoma	0.000378	0.00106	CcSEcCtD
Cyclophosphamide—Hepatic failure—Docetaxel—melanoma	0.000376	0.00105	CcSEcCtD
Cyclophosphamide—Chills—Bleomycin—melanoma	0.000374	0.00105	CcSEcCtD
Cyclophosphamide—Cardiac failure congestive—Docetaxel—melanoma	0.000373	0.00104	CcSEcCtD
Cyclophosphamide—Alopecia—Bleomycin—melanoma	0.000368	0.00103	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Dactinomycin—melanoma	0.000368	0.00103	CcSEcCtD
Cyclophosphamide—Haemoglobin—Carmustine—melanoma	0.000366	0.00102	CcSEcCtD
Cyclophosphamide—Haemorrhage—Carmustine—melanoma	0.000364	0.00102	CcSEcCtD
Cyclophosphamide—Erythema—Bleomycin—melanoma	0.000363	0.00102	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Carmustine—melanoma	0.000362	0.00101	CcSEcCtD
Cyclophosphamide—Hot flush—Docetaxel—melanoma	0.000361	0.00101	CcSEcCtD
Cyclophosphamide—Flushing—Dactinomycin—melanoma	0.000361	0.00101	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Vemurafenib—melanoma	0.00036	0.00101	CcSEcCtD
Cyclophosphamide—Menopausal symptoms—Docetaxel—melanoma	0.000358	0.001	CcSEcCtD
Cyclophosphamide—Atrial fibrillation—Docetaxel—melanoma	0.000357	0.000998	CcSEcCtD
Cyclophosphamide—Renal impairment—Docetaxel—melanoma	0.000355	0.000994	CcSEcCtD
Cyclophosphamide—Dermatitis bullous—Docetaxel—melanoma	0.000354	0.00099	CcSEcCtD
Cyclophosphamide—Haemoglobin—Temozolomide—melanoma	0.000354	0.000989	CcSEcCtD
Cyclophosphamide—Haemorrhage—Temozolomide—melanoma	0.000352	0.000984	CcSEcCtD
Cyclophosphamide—Hepatitis—Temozolomide—melanoma	0.000352	0.000984	CcSEcCtD
Cyclophosphamide—Asthenia—Vemurafenib—melanoma	0.000351	0.000981	CcSEcCtD
Cyclophosphamide—Visual impairment—Carmustine—melanoma	0.000351	0.000981	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Temozolomide—melanoma	0.00035	0.000979	CcSEcCtD
Cyclophosphamide—Chills—Dactinomycin—melanoma	0.000349	0.000976	CcSEcCtD
Cyclophosphamide—Cardiac failure—Docetaxel—melanoma	0.000346	0.000969	CcSEcCtD
Cyclophosphamide—Pruritus—Vemurafenib—melanoma	0.000346	0.000968	CcSEcCtD
Cyclophosphamide—Alopecia—Dactinomycin—melanoma	0.000344	0.000961	CcSEcCtD
Cyclophosphamide—Hyponatraemia—Docetaxel—melanoma	0.000339	0.00095	CcSEcCtD
Cyclophosphamide—Visual impairment—Temozolomide—melanoma	0.000339	0.000948	CcSEcCtD
Cyclophosphamide—Erythema—Dactinomycin—melanoma	0.000339	0.000947	CcSEcCtD
Cyclophosphamide—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000338	0.000946	CcSEcCtD
Cyclophosphamide—Flushing—Carmustine—melanoma	0.000338	0.000945	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Bleomycin—melanoma	0.000337	0.000942	CcSEcCtD
Cyclophosphamide—Anaemia—Bleomycin—melanoma	0.000335	0.000938	CcSEcCtD
Cyclophosphamide—Diarrhoea—Vemurafenib—melanoma	0.000335	0.000936	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Temozolomide—melanoma	0.000333	0.00093	CcSEcCtD
Cyclophosphamide—Tinnitus—Temozolomide—melanoma	0.000328	0.000917	CcSEcCtD
Cyclophosphamide—Malaise—Bleomycin—melanoma	0.000327	0.000916	CcSEcCtD
Cyclophosphamide—Flushing—Temozolomide—melanoma	0.000326	0.000913	CcSEcCtD
Cyclophosphamide—Arrhythmia—Carmustine—melanoma	0.000325	0.00091	CcSEcCtD
Cyclophosphamide—Leukopenia—Bleomycin—melanoma	0.000325	0.000909	CcSEcCtD
Cyclophosphamide—Dizziness—Vemurafenib—melanoma	0.000323	0.000904	CcSEcCtD
Cyclophosphamide—Alopecia—Carmustine—melanoma	0.000322	0.0009	CcSEcCtD
Cyclophosphamide—Erythema—Carmustine—melanoma	0.000317	0.000886	CcSEcCtD
Cyclophosphamide—Cough—Bleomycin—melanoma	0.000317	0.000886	CcSEcCtD
Cyclophosphamide—Chills—Temozolomide—melanoma	0.000316	0.000883	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Dactinomycin—melanoma	0.000314	0.000879	CcSEcCtD
Cyclophosphamide—Anaemia—Dactinomycin—melanoma	0.000313	0.000875	CcSEcCtD
Cyclophosphamide—Vomiting—Vemurafenib—melanoma	0.000311	0.00087	CcSEcCtD
Cyclophosphamide—Alopecia—Temozolomide—melanoma	0.000311	0.000869	CcSEcCtD
Cyclophosphamide—Chest pain—Bleomycin—melanoma	0.000309	0.000864	CcSEcCtD
Cyclophosphamide—Myalgia—Bleomycin—melanoma	0.000309	0.000864	CcSEcCtD
Cyclophosphamide—Rash—Vemurafenib—melanoma	0.000308	0.000862	CcSEcCtD
Cyclophosphamide—Dermatitis—Vemurafenib—melanoma	0.000308	0.000862	CcSEcCtD
Cyclophosphamide—Headache—Vemurafenib—melanoma	0.000306	0.000857	CcSEcCtD
Cyclophosphamide—Erythema—Temozolomide—melanoma	0.000306	0.000857	CcSEcCtD
Cyclophosphamide—Discomfort—Bleomycin—melanoma	0.000305	0.000854	CcSEcCtD
Cyclophosphamide—Malaise—Dactinomycin—melanoma	0.000305	0.000854	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000304	0.000852	CcSEcCtD
Cyclophosphamide—Leukopenia—Dactinomycin—melanoma	0.000303	0.000848	CcSEcCtD
Cyclophosphamide—Nasopharyngitis—Docetaxel—melanoma	0.000302	0.000846	CcSEcCtD
Cyclophosphamide—Dysgeusia—Temozolomide—melanoma	0.0003	0.000839	CcSEcCtD
Cyclophosphamide—Confusional state—Bleomycin—melanoma	0.000299	0.000836	CcSEcCtD
Cyclophosphamide—Vision blurred—Carmustine—melanoma	0.000299	0.000835	CcSEcCtD
Cyclophosphamide—Tremor—Carmustine—melanoma	0.000297	0.00083	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Bleomycin—melanoma	0.000296	0.000829	CcSEcCtD
Cyclophosphamide—Oedema—Bleomycin—melanoma	0.000296	0.000829	CcSEcCtD
Cyclophosphamide—Infection—Bleomycin—melanoma	0.000294	0.000823	CcSEcCtD
Cyclophosphamide—Anaemia—Carmustine—melanoma	0.000293	0.000819	CcSEcCtD
Cyclophosphamide—Agitation—Carmustine—melanoma	0.000291	0.000814	CcSEcCtD
Cyclophosphamide—Nausea—Vemurafenib—melanoma	0.00029	0.000812	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Bleomycin—melanoma	0.00029	0.000811	CcSEcCtD
Cyclophosphamide—Vision blurred—Temozolomide—melanoma	0.000289	0.000807	CcSEcCtD
Cyclophosphamide—Myalgia—Dactinomycin—melanoma	0.000288	0.000806	CcSEcCtD
Cyclophosphamide—Bronchospasm—Docetaxel—melanoma	0.000287	0.000804	CcSEcCtD
Cyclophosphamide—Tremor—Temozolomide—melanoma	0.000287	0.000802	CcSEcCtD
Cyclophosphamide—Discomfort—Dactinomycin—melanoma	0.000285	0.000797	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Temozolomide—melanoma	0.000284	0.000795	CcSEcCtD
Cyclophosphamide—Leukopenia—Carmustine—melanoma	0.000284	0.000793	CcSEcCtD
Cyclophosphamide—Anaemia—Temozolomide—melanoma	0.000283	0.000792	CcSEcCtD
Cyclophosphamide—Anorexia—Bleomycin—melanoma	0.000282	0.00079	CcSEcCtD
Cyclophosphamide—Agitation—Temozolomide—melanoma	0.000281	0.000787	CcSEcCtD
Cyclophosphamide—Pancytopenia—Docetaxel—melanoma	0.000278	0.000776	CcSEcCtD
Cyclophosphamide—Hypotension—Bleomycin—melanoma	0.000277	0.000774	CcSEcCtD
Cyclophosphamide—Oedema—Dactinomycin—melanoma	0.000276	0.000773	CcSEcCtD
Cyclophosphamide—Malaise—Temozolomide—melanoma	0.000276	0.000772	CcSEcCtD
Cyclophosphamide—Convulsion—Carmustine—melanoma	0.000275	0.000768	CcSEcCtD
Cyclophosphamide—Infection—Dactinomycin—melanoma	0.000274	0.000768	CcSEcCtD
Cyclophosphamide—Leukopenia—Temozolomide—melanoma	0.000274	0.000767	CcSEcCtD
Cyclophosphamide—Hypertension—Carmustine—melanoma	0.000274	0.000765	CcSEcCtD
Cyclophosphamide—Palpitations—Temozolomide—melanoma	0.000271	0.000757	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Dactinomycin—melanoma	0.000271	0.000757	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Bleomycin—melanoma	0.00027	0.000755	CcSEcCtD
Cyclophosphamide—Chest pain—Carmustine—melanoma	0.00027	0.000755	CcSEcCtD
Cyclophosphamide—Myalgia—Carmustine—melanoma	0.00027	0.000755	CcSEcCtD
Cyclophosphamide—Cough—Temozolomide—melanoma	0.000267	0.000747	CcSEcCtD
Cyclophosphamide—Paraesthesia—Bleomycin—melanoma	0.000266	0.000744	CcSEcCtD
Cyclophosphamide—Weight increased—Docetaxel—melanoma	0.000266	0.000744	CcSEcCtD
Cyclophosphamide—Convulsion—Temozolomide—melanoma	0.000265	0.000742	CcSEcCtD
Cyclophosphamide—Hypertension—Temozolomide—melanoma	0.000264	0.000739	CcSEcCtD
Cyclophosphamide—Dyspnoea—Bleomycin—melanoma	0.000264	0.000739	CcSEcCtD
Cyclophosphamide—Anorexia—Dactinomycin—melanoma	0.000263	0.000737	CcSEcCtD
Cyclophosphamide—Pneumonia—Docetaxel—melanoma	0.000262	0.000733	CcSEcCtD
Cyclophosphamide—Confusional state—Carmustine—melanoma	0.000261	0.000729	CcSEcCtD
Cyclophosphamide—Arthralgia—Temozolomide—melanoma	0.000261	0.000729	CcSEcCtD
Cyclophosphamide—Myalgia—Temozolomide—melanoma	0.000261	0.000729	CcSEcCtD
Cyclophosphamide—Oedema—Carmustine—melanoma	0.000259	0.000723	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000258	0.000723	CcSEcCtD
Cyclophosphamide—Discomfort—Temozolomide—melanoma	0.000258	0.00072	CcSEcCtD
Cyclophosphamide—Decreased appetite—Bleomycin—melanoma	0.000258	0.00072	CcSEcCtD
Cyclophosphamide—Infection—Carmustine—melanoma	0.000257	0.000719	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Docetaxel—melanoma	0.000257	0.000719	CcSEcCtD
Cyclophosphamide—Renal failure—Docetaxel—melanoma	0.000256	0.000716	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Docetaxel—melanoma	0.000255	0.000714	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Docetaxel—melanoma	0.000255	0.000714	CcSEcCtD
Cyclophosphamide—Jaundice—Docetaxel—melanoma	0.000254	0.00071	CcSEcCtD
Cyclophosphamide—Stomatitis—Docetaxel—melanoma	0.000254	0.00071	CcSEcCtD
Cyclophosphamide—Pain—Bleomycin—melanoma	0.000253	0.000709	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Docetaxel—melanoma	0.000253	0.000708	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Carmustine—melanoma	0.000253	0.000708	CcSEcCtD
Cyclophosphamide—Tachycardia—Carmustine—melanoma	0.000252	0.000706	CcSEcCtD
Cyclophosphamide—Confusional state—Temozolomide—melanoma	0.000252	0.000705	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000252	0.000704	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Temozolomide—melanoma	0.00025	0.000699	CcSEcCtD
Cyclophosphamide—Oedema—Temozolomide—melanoma	0.00025	0.000699	CcSEcCtD
Cyclophosphamide—Infection—Temozolomide—melanoma	0.000248	0.000694	CcSEcCtD
Cyclophosphamide—Anorexia—Carmustine—melanoma	0.000246	0.00069	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Temozolomide—melanoma	0.000245	0.000684	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Bleomycin—melanoma	0.000244	0.000683	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Docetaxel—melanoma	0.000243	0.00068	CcSEcCtD
Cyclophosphamide—Hypotension—Carmustine—melanoma	0.000242	0.000676	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Temozolomide—melanoma	0.000242	0.000676	CcSEcCtD
Cyclophosphamide—Decreased appetite—Dactinomycin—melanoma	0.00024	0.000672	CcSEcCtD
Cyclophosphamide—Fatigue—Dactinomycin—melanoma	0.000238	0.000666	CcSEcCtD
Cyclophosphamide—Anorexia—Temozolomide—melanoma	0.000238	0.000666	CcSEcCtD
Cyclophosphamide—Pain—Dactinomycin—melanoma	0.000236	0.000661	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Carmustine—melanoma	0.000236	0.000659	CcSEcCtD
Cyclophosphamide—Urticaria—Bleomycin—melanoma	0.000235	0.000658	CcSEcCtD
Cyclophosphamide—Haemoglobin—Docetaxel—melanoma	0.000235	0.000658	CcSEcCtD
Cyclophosphamide—Rhinitis—Docetaxel—melanoma	0.000234	0.000656	CcSEcCtD
Cyclophosphamide—Body temperature increased—Bleomycin—melanoma	0.000234	0.000655	CcSEcCtD
Cyclophosphamide—Haemorrhage—Docetaxel—melanoma	0.000234	0.000654	CcSEcCtD
Cyclophosphamide—Hepatitis—Docetaxel—melanoma	0.000234	0.000654	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Docetaxel—melanoma	0.000233	0.000651	CcSEcCtD
Cyclophosphamide—Paraesthesia—Carmustine—melanoma	0.000232	0.00065	CcSEcCtD
Cyclophosphamide—Dyspnoea—Carmustine—melanoma	0.000231	0.000645	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Dactinomycin—melanoma	0.000228	0.000637	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000228	0.000637	CcSEcCtD
Cyclophosphamide—Visual impairment—Docetaxel—melanoma	0.000225	0.000631	CcSEcCtD
Cyclophosphamide—Decreased appetite—Carmustine—melanoma	0.000225	0.000629	CcSEcCtD
Cyclophosphamide—Paraesthesia—Temozolomide—melanoma	0.000224	0.000628	CcSEcCtD
Cyclophosphamide—Dyspnoea—Temozolomide—melanoma	0.000223	0.000623	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Docetaxel—melanoma	0.000221	0.000619	CcSEcCtD
Cyclophosphamide—Pain—Carmustine—melanoma	0.000221	0.000619	CcSEcCtD
Cyclophosphamide—Constipation—Carmustine—melanoma	0.000221	0.000619	CcSEcCtD
Cyclophosphamide—Body temperature increased—Dactinomycin—melanoma	0.000218	0.000611	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Bleomycin—melanoma	0.000218	0.000611	CcSEcCtD
Cyclophosphamide—Decreased appetite—Temozolomide—melanoma	0.000217	0.000608	CcSEcCtD
Cyclophosphamide—Flushing—Docetaxel—melanoma	0.000217	0.000607	CcSEcCtD
Cyclophosphamide—Fatigue—Temozolomide—melanoma	0.000215	0.000603	CcSEcCtD
Cyclophosphamide—Pain—Temozolomide—melanoma	0.000214	0.000598	CcSEcCtD
Cyclophosphamide—Constipation—Temozolomide—melanoma	0.000214	0.000598	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Carmustine—melanoma	0.000213	0.000596	CcSEcCtD
Cyclophosphamide—Asthenia—Bleomycin—melanoma	0.000213	0.000595	CcSEcCtD
Cyclophosphamide—Chills—Docetaxel—melanoma	0.00021	0.000587	CcSEcCtD
Cyclophosphamide—Pruritus—Bleomycin—melanoma	0.00021	0.000586	CcSEcCtD
Cyclophosphamide—Arrhythmia—Docetaxel—melanoma	0.000209	0.000585	CcSEcCtD
Cyclophosphamide—Alopecia—Docetaxel—melanoma	0.000207	0.000578	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Temozolomide—melanoma	0.000206	0.000576	CcSEcCtD
Cyclophosphamide—Body temperature increased—Carmustine—melanoma	0.000204	0.000572	CcSEcCtD
Cyclophosphamide—Erythema—Docetaxel—melanoma	0.000204	0.00057	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Dactinomycin—melanoma	0.000204	0.000569	CcSEcCtD
Cyclophosphamide—Dysgeusia—Docetaxel—melanoma	0.000199	0.000558	CcSEcCtD
Cyclophosphamide—Urticaria—Temozolomide—melanoma	0.000199	0.000555	CcSEcCtD
Cyclophosphamide—Asthenia—Dactinomycin—melanoma	0.000198	0.000555	CcSEcCtD
Cyclophosphamide—Body temperature increased—Temozolomide—melanoma	0.000198	0.000553	CcSEcCtD
Cyclophosphamide—Muscle spasms—Docetaxel—melanoma	0.000196	0.000548	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Carmustine—melanoma	0.000191	0.000533	CcSEcCtD
Cyclophosphamide—Diarrhoea—Dactinomycin—melanoma	0.000189	0.000529	CcSEcCtD
Cyclophosphamide—Vomiting—Bleomycin—melanoma	0.000188	0.000527	CcSEcCtD
Cyclophosphamide—Anaemia—Docetaxel—melanoma	0.000188	0.000526	CcSEcCtD
Cyclophosphamide—Rash—Bleomycin—melanoma	0.000187	0.000522	CcSEcCtD
Cyclophosphamide—Dermatitis—Bleomycin—melanoma	0.000187	0.000522	CcSEcCtD
Cyclophosphamide—Asthenia—Carmustine—melanoma	0.000186	0.000519	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Temozolomide—melanoma	0.000184	0.000515	CcSEcCtD
Cyclophosphamide—Leukopenia—Docetaxel—melanoma	0.000182	0.00051	CcSEcCtD
Cyclophosphamide—Palpitations—Docetaxel—melanoma	0.00018	0.000503	CcSEcCtD
Cyclophosphamide—Asthenia—Temozolomide—melanoma	0.000179	0.000502	CcSEcCtD
Cyclophosphamide—Cough—Docetaxel—melanoma	0.000178	0.000497	CcSEcCtD
Cyclophosphamide—Diarrhoea—Carmustine—melanoma	0.000177	0.000495	CcSEcCtD
Cyclophosphamide—Pruritus—Temozolomide—melanoma	0.000177	0.000495	CcSEcCtD
Cyclophosphamide—Convulsion—Docetaxel—melanoma	0.000176	0.000494	CcSEcCtD
Cyclophosphamide—Nausea—Bleomycin—melanoma	0.000176	0.000492	CcSEcCtD
Cyclophosphamide—Hypertension—Docetaxel—melanoma	0.000176	0.000492	CcSEcCtD
Cyclophosphamide—Vomiting—Dactinomycin—melanoma	0.000176	0.000491	CcSEcCtD
Cyclophosphamide—Rash—Dactinomycin—melanoma	0.000174	0.000487	CcSEcCtD
Cyclophosphamide—Chest pain—Docetaxel—melanoma	0.000173	0.000485	CcSEcCtD
Cyclophosphamide—Arthralgia—Docetaxel—melanoma	0.000173	0.000485	CcSEcCtD
Cyclophosphamide—Myalgia—Docetaxel—melanoma	0.000173	0.000485	CcSEcCtD
Cyclophosphamide—Dizziness—Carmustine—melanoma	0.000171	0.000478	CcSEcCtD
Cyclophosphamide—Diarrhoea—Temozolomide—melanoma	0.000171	0.000478	CcSEcCtD
Cyclophosphamide—Confusional state—Docetaxel—melanoma	0.000168	0.000469	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Docetaxel—melanoma	0.000166	0.000465	CcSEcCtD
Cyclophosphamide—Oedema—Docetaxel—melanoma	0.000166	0.000465	CcSEcCtD
Cyclophosphamide—Dizziness—Temozolomide—melanoma	0.000165	0.000462	CcSEcCtD
Cyclophosphamide—Infection—Docetaxel—melanoma	0.000165	0.000462	CcSEcCtD
Cyclophosphamide—Vomiting—Carmustine—melanoma	0.000164	0.00046	CcSEcCtD
Cyclophosphamide—Nausea—Dactinomycin—melanoma	0.000164	0.000459	CcSEcCtD
Cyclophosphamide—Shock—Docetaxel—melanoma	0.000163	0.000457	CcSEcCtD
Cyclophosphamide—Rash—Carmustine—melanoma	0.000163	0.000456	CcSEcCtD
Cyclophosphamide—Dermatitis—Carmustine—melanoma	0.000163	0.000456	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Docetaxel—melanoma	0.000163	0.000455	CcSEcCtD
Cyclophosphamide—Tachycardia—Docetaxel—melanoma	0.000162	0.000454	CcSEcCtD
Cyclophosphamide—Headache—Carmustine—melanoma	0.000162	0.000453	CcSEcCtD
Cyclophosphamide—Vomiting—Temozolomide—melanoma	0.000159	0.000444	CcSEcCtD
Cyclophosphamide—Anorexia—Docetaxel—melanoma	0.000158	0.000443	CcSEcCtD
Cyclophosphamide—Rash—Temozolomide—melanoma	0.000158	0.000441	CcSEcCtD
Cyclophosphamide—Dermatitis—Temozolomide—melanoma	0.000157	0.00044	CcSEcCtD
Cyclophosphamide—Headache—Temozolomide—melanoma	0.000157	0.000438	CcSEcCtD
Cyclophosphamide—Hypotension—Docetaxel—melanoma	0.000155	0.000434	CcSEcCtD
Cyclophosphamide—Nausea—Carmustine—melanoma	0.000154	0.00043	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000151	0.000424	CcSEcCtD
Cyclophosphamide—Paraesthesia—Docetaxel—melanoma	0.000149	0.000417	CcSEcCtD
Cyclophosphamide—Nausea—Temozolomide—melanoma	0.000148	0.000415	CcSEcCtD
Cyclophosphamide—Dyspnoea—Docetaxel—melanoma	0.000148	0.000414	CcSEcCtD
Cyclophosphamide—Decreased appetite—Docetaxel—melanoma	0.000144	0.000404	CcSEcCtD
Cyclophosphamide—Fatigue—Docetaxel—melanoma	0.000143	0.000401	CcSEcCtD
Cyclophosphamide—Constipation—Docetaxel—melanoma	0.000142	0.000398	CcSEcCtD
Cyclophosphamide—Pain—Docetaxel—melanoma	0.000142	0.000398	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Docetaxel—melanoma	0.000137	0.000383	CcSEcCtD
Cyclophosphamide—Body temperature increased—Docetaxel—melanoma	0.000131	0.000367	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Docetaxel—melanoma	0.000122	0.000342	CcSEcCtD
Cyclophosphamide—Asthenia—Docetaxel—melanoma	0.000119	0.000334	CcSEcCtD
Cyclophosphamide—Pruritus—Docetaxel—melanoma	0.000118	0.000329	CcSEcCtD
Cyclophosphamide—Diarrhoea—Docetaxel—melanoma	0.000114	0.000318	CcSEcCtD
Cyclophosphamide—Dizziness—Docetaxel—melanoma	0.00011	0.000307	CcSEcCtD
Cyclophosphamide—Vomiting—Docetaxel—melanoma	0.000106	0.000296	CcSEcCtD
Cyclophosphamide—Rash—Docetaxel—melanoma	0.000105	0.000293	CcSEcCtD
Cyclophosphamide—Dermatitis—Docetaxel—melanoma	0.000105	0.000293	CcSEcCtD
Cyclophosphamide—Headache—Docetaxel—melanoma	0.000104	0.000291	CcSEcCtD
Cyclophosphamide—Nausea—Docetaxel—melanoma	9.87e-05	0.000276	CcSEcCtD
Cyclophosphamide—CYP2D6—Metabolism—CSPG4—melanoma	9.95e-06	0.000315	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—BSG—melanoma	9.95e-06	0.000315	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—SDHD—melanoma	9.86e-06	0.000312	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CSPG4—melanoma	9.86e-06	0.000312	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—BSG—melanoma	9.86e-06	0.000312	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	9.74e-06	0.000309	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CD44—melanoma	9.72e-06	0.000308	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GNAQ—melanoma	9.72e-06	0.000308	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GPAM—melanoma	9.63e-06	0.000305	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GPAM—melanoma	9.55e-06	0.000303	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	9.53e-06	0.000302	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	9.53e-06	0.000302	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CYP1B1—melanoma	9.32e-06	0.000295	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CG—melanoma	9.08e-06	0.000288	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	9.07e-06	0.000287	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	9e-06	0.000285	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—VCAN—melanoma	8.96e-06	0.000284	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP17A1—melanoma	8.93e-06	0.000283	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PLA2G6—melanoma	8.91e-06	0.000282	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PPARG—melanoma	8.76e-06	0.000278	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP17A1—melanoma	8.73e-06	0.000277	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PLA2G6—melanoma	8.69e-06	0.000275	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLCB4—melanoma	8.58e-06	0.000272	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.48e-06	0.000269	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GNA11—melanoma	8.44e-06	0.000267	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ABCB1—melanoma	8.37e-06	0.000265	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	8.27e-06	0.000262	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—FASN—melanoma	8.26e-06	0.000262	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GNA11—melanoma	8.25e-06	0.000261	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PLA2G6—melanoma	8.19e-06	0.00026	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.19e-06	0.000259	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PLA2G6—melanoma	8.12e-06	0.000257	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—SLC5A5—melanoma	8.12e-06	0.000257	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC6A11—melanoma	8.07e-06	0.000256	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIP4K2A—melanoma	8.07e-06	0.000256	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—FASN—melanoma	8.07e-06	0.000256	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—VCAN—melanoma	8e-06	0.000253	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	8e-06	0.000253	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CD—melanoma	7.98e-06	0.000253	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—SLC5A5—melanoma	7.94e-06	0.000251	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—ALB—melanoma	7.88e-06	0.00025	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—MTAP—melanoma	7.85e-06	0.000249	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GNAQ—melanoma	7.84e-06	0.000248	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CD44—melanoma	7.84e-06	0.000248	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—VCAN—melanoma	7.81e-06	0.000247	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PRKCA—melanoma	7.71e-06	0.000244	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ABCB1—melanoma	7.67e-06	0.000243	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CD44—melanoma	7.67e-06	0.000243	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GNAQ—melanoma	7.67e-06	0.000243	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ERCC2—melanoma	7.64e-06	0.000242	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.57e-06	0.00024	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP17A1—melanoma	7.56e-06	0.00024	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP1B1—melanoma	7.52e-06	0.000238	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.46e-06	0.000236	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	7.36e-06	0.000233	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—VCAN—melanoma	7.36e-06	0.000233	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP1B1—melanoma	7.35e-06	0.000233	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.31e-06	0.000232	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—VCAN—melanoma	7.3e-06	0.000231	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GNA11—melanoma	7.14e-06	0.000226	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PRKCA—melanoma	7.06e-06	0.000224	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ERCC2—melanoma	7e-06	0.000222	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PHGDH—melanoma	7e-06	0.000222	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LUM—melanoma	7e-06	0.000222	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—FASN—melanoma	6.99e-06	0.000221	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CB—melanoma	6.96e-06	0.00022	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.91e-06	0.000219	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTGS2—melanoma	6.89e-06	0.000218	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—SLC5A5—melanoma	6.87e-06	0.000218	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HPSE—melanoma	6.86e-06	0.000217	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	6.75e-06	0.000214	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP17A1—melanoma	6.75e-06	0.000214	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CUBN—melanoma	6.73e-06	0.000213	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.66e-06	0.000211	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.66e-06	0.000211	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CD44—melanoma	6.64e-06	0.00021	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GNAQ—melanoma	6.64e-06	0.00021	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP17A1—melanoma	6.59e-06	0.000209	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	6.57e-06	0.000208	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SDHD—melanoma	6.5e-06	0.000206	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CSPG4—melanoma	6.5e-06	0.000206	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—BSG—melanoma	6.5e-06	0.000206	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.5e-06	0.000206	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.44e-06	0.000204	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GNA11—melanoma	6.37e-06	0.000202	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP1B1—melanoma	6.37e-06	0.000202	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GPAM—melanoma	6.3e-06	0.0002	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—FASN—melanoma	6.24e-06	0.000198	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GNA11—melanoma	6.22e-06	0.000197	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP17A1—melanoma	6.21e-06	0.000197	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ABCB1—melanoma	6.19e-06	0.000196	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP17A1—melanoma	6.16e-06	0.000195	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—SLC5A5—melanoma	6.14e-06	0.000194	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	6.1e-06	0.000193	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—FASN—melanoma	6.09e-06	0.000193	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.07e-06	0.000192	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ABCB1—melanoma	6.05e-06	0.000192	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CG—melanoma	6.04e-06	0.000191	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTEN—melanoma	6.01e-06	0.00019	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	5.99e-06	0.00019	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—SLC5A5—melanoma	5.99e-06	0.00019	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GNAQ—melanoma	5.93e-06	0.000188	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CD44—melanoma	5.93e-06	0.000188	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GNA11—melanoma	5.86e-06	0.000186	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PPARG—melanoma	5.82e-06	0.000185	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GNA11—melanoma	5.81e-06	0.000184	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.8e-06	0.000184	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GNAQ—melanoma	5.78e-06	0.000183	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CD44—melanoma	5.78e-06	0.000183	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.75e-06	0.000182	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—FASN—melanoma	5.74e-06	0.000182	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PRKCA—melanoma	5.7e-06	0.000181	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—FASN—melanoma	5.69e-06	0.00018	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP1B1—melanoma	5.68e-06	0.00018	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ERCC2—melanoma	5.65e-06	0.000179	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—SLC5A5—melanoma	5.64e-06	0.000179	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.62e-06	0.000178	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—SLC5A5—melanoma	5.6e-06	0.000177	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PRKCA—melanoma	5.57e-06	0.000176	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP1B1—melanoma	5.55e-06	0.000176	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CG—melanoma	5.53e-06	0.000175	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ERCC2—melanoma	5.52e-06	0.000175	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GNAQ—melanoma	5.45e-06	0.000173	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CD44—melanoma	5.45e-06	0.000173	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GNAQ—melanoma	5.4e-06	0.000171	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CD44—melanoma	5.4e-06	0.000171	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLA2G6—melanoma	5.36e-06	0.00017	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PPARG—melanoma	5.34e-06	0.000169	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CD—melanoma	5.31e-06	0.000168	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.29e-06	0.000168	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.24e-06	0.000166	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ABCB1—melanoma	5.24e-06	0.000166	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ALB—melanoma	5.24e-06	0.000166	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP1B1—melanoma	5.23e-06	0.000166	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP1B1—melanoma	5.18e-06	0.000164	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.01e-06	0.000159	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CD—melanoma	4.86e-06	0.000154	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PRKCA—melanoma	4.82e-06	0.000153	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—VCAN—melanoma	4.81e-06	0.000152	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ALB—melanoma	4.8e-06	0.000152	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ERCC2—melanoma	4.78e-06	0.000152	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ABCB1—melanoma	4.68e-06	0.000148	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CB—melanoma	4.62e-06	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS2—melanoma	4.58e-06	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.57e-06	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CG—melanoma	4.46e-06	0.000141	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CG—melanoma	4.36e-06	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPARG—melanoma	4.31e-06	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PRKCA—melanoma	4.31e-06	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ABCB1—melanoma	4.3e-06	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ERCC2—melanoma	4.27e-06	0.000135	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ABCB1—melanoma	4.27e-06	0.000135	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CA—melanoma	4.24e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CB—melanoma	4.24e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPARG—melanoma	4.21e-06	0.000133	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PRKCA—melanoma	4.2e-06	0.000133	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS2—melanoma	4.2e-06	0.000133	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ERCC2—melanoma	4.17e-06	0.000132	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP17A1—melanoma	4.06e-06	0.000129	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTEN—melanoma	4e-06	0.000127	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.96e-06	0.000126	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PRKCA—melanoma	3.96e-06	0.000125	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ERCC2—melanoma	3.93e-06	0.000124	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PRKCA—melanoma	3.93e-06	0.000124	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CD—melanoma	3.92e-06	0.000124	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ERCC2—melanoma	3.89e-06	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ALB—melanoma	3.87e-06	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CD—melanoma	3.84e-06	0.000121	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GNA11—melanoma	3.83e-06	0.000121	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ALB—melanoma	3.79e-06	0.00012	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CG—melanoma	3.78e-06	0.00012	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—FASN—melanoma	3.75e-06	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC5A5—melanoma	3.69e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTEN—melanoma	3.66e-06	0.000116	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARG—melanoma	3.65e-06	0.000116	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GNAQ—melanoma	3.56e-06	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CD44—melanoma	3.56e-06	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.54e-06	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—AKT1—melanoma	3.46e-06	0.00011	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CB—melanoma	3.42e-06	0.000108	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP1B1—melanoma	3.42e-06	0.000108	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS2—melanoma	3.39e-06	0.000107	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CG—melanoma	3.37e-06	0.000107	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CB—melanoma	3.34e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CD—melanoma	3.32e-06	0.000105	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS2—melanoma	3.31e-06	0.000105	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CG—melanoma	3.29e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ALB—melanoma	3.28e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARG—melanoma	3.26e-06	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.23e-06	0.000102	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARG—melanoma	3.18e-06	0.000101	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CG—melanoma	3.1e-06	9.83e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CG—melanoma	3.08e-06	9.74e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARG—melanoma	2.99e-06	9.48e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARG—melanoma	2.97e-06	9.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CD—melanoma	2.97e-06	9.39e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTEN—melanoma	2.96e-06	9.36e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALB—melanoma	2.93e-06	9.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CB—melanoma	2.9e-06	9.17e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CD—melanoma	2.89e-06	9.17e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTEN—melanoma	2.89e-06	9.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS2—melanoma	2.87e-06	9.09e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALB—melanoma	2.86e-06	9.05e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CA—melanoma	2.82e-06	8.93e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ABCB1—melanoma	2.81e-06	8.91e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CD—melanoma	2.73e-06	8.64e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CD—melanoma	2.7e-06	8.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALB—melanoma	2.69e-06	8.53e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALB—melanoma	2.67e-06	8.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PRKCA—melanoma	2.59e-06	8.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CB—melanoma	2.58e-06	8.19e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CA—melanoma	2.58e-06	8.19e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ERCC2—melanoma	2.57e-06	8.14e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS2—melanoma	2.56e-06	8.11e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CB—melanoma	2.52e-06	7.99e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTEN—melanoma	2.5e-06	7.93e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS2—melanoma	2.5e-06	7.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CB—melanoma	2.38e-06	7.53e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CB—melanoma	2.36e-06	7.47e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS2—melanoma	2.36e-06	7.46e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS2—melanoma	2.33e-06	7.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—AKT1—melanoma	2.3e-06	7.3e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTEN—melanoma	2.23e-06	7.07e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTEN—melanoma	2.18e-06	6.91e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—AKT1—melanoma	2.11e-06	6.69e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CA—melanoma	2.08e-06	6.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTEN—melanoma	2.05e-06	6.51e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CA—melanoma	2.04e-06	6.46e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTEN—melanoma	2.04e-06	6.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CG—melanoma	2.03e-06	6.43e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARG—melanoma	1.96e-06	6.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CD—melanoma	1.78e-06	5.65e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CA—melanoma	1.77e-06	5.59e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALB—melanoma	1.76e-06	5.58e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AKT1—melanoma	1.7e-06	5.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AKT1—melanoma	1.66e-06	5.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CA—melanoma	1.58e-06	4.99e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CB—melanoma	1.55e-06	4.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS2—melanoma	1.54e-06	4.88e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CA—melanoma	1.54e-06	4.87e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CA—melanoma	1.45e-06	4.59e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AKT1—melanoma	1.44e-06	4.57e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CA—melanoma	1.44e-06	4.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTEN—melanoma	1.34e-06	4.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AKT1—melanoma	1.29e-06	4.08e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AKT1—melanoma	1.26e-06	3.98e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AKT1—melanoma	1.18e-06	3.75e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AKT1—melanoma	1.17e-06	3.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CA—melanoma	9.47e-07	3e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AKT1—melanoma	7.74e-07	2.45e-05	CbGpPWpGaD
